Digital PCR (dPCR) and Real-time PCR (qPCR) Industry worth $14.8 billion by 2029, with a CAGR of 8.1%
The report "Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Offering (Product (Reagents & Consumables, Instrument), Software, Services), Application (Clinical (infectious, Oncology), Research, Forensic, Environmental) - Global Forecast to 2029", global Digital PCR (dPCR) and Real-time PCR (qPCR) market is projected to reach USD 14.8 billion by 2029 from USD 10.0 billion in 2024, at a CAGR of 8.1% during the forecast period of 2024 to 2029. Some factors contributing to the growth of the global market include increased use of dPCR and qPCR technologies for point of care (POC) diagnostics, continuous advancements in PCR technologies and growing importance of PCR in biomarker discovery. Despite this, unfavorable reimbursement scenario for diagnostic companies, and technical limitations of qPCR and dPCR are expected to hinder market growth.
Browse 907 market data Tables and 58 Figures spread through 598 Pages and in-depth TOC on "Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Offering (Product (Reagents & Consumables, Instrument), Software, Services), Application (Clinical (infectious, Oncology), Research, Forensic, Environmental) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/digital-pcr-market-174151204.html
The product segment accounted for the largest share of the offering segment in the Digital PCR (dPCR) and Real-time PCR (qPCR) market in 2023.
Based on offering, the Digital PCR (dPCR) and Real-time PCR (qPCR) market is segmented into product, software, and services. Product segment comprised of reagent and consumables, and instrument for dPCR and qPCR dominated the market in 2023 and are expected to dominate the market in the forecast period. High growth of this product segment due to several factors such as increasing demand for precise and efficient genomic analysis, advancements in biotechnology driving innovation in reagents and kits. qPCR/dPCR instruments segment is likely to grow at significant CAGR during the forecast period of 2024-2029 owing to technological advancements enhancing instrument sensitivity and throughput and increasing adoption in clinical diagnostics and research.
The clinical application segment is estimated to register the highest growth rate during the forecast period in the qPCR market.
Based on application, the Digital PCR (dPCR) and Real-time PCR (qPCR) market is further segmented into clinical applications, research applications, environmental applications, forensic applications and other applications. The clinical applications segment is estimated to account for the largest market share during the forecast period. The key factors driving the market growth include the growing adoption of qPCR and dPCR in disease diagnosis, rising incidence of chronic diseases, and growing demand for early & effective disease diagnosis & treatment. However, the unavailability of reimbursements for clinical diagnostic tests in prominent and emerging countries and the availability of alternative affordable disease diagnosis techniques (such as traditional microbiology techniques and rapid diagnostic tests) are factors expected to hinder the market growth.
The Asia Pacific region will be the fastest-growing region of the Digital PCR (dPCR) and Real-time PCR (qPCR) in 2023.
Based on the region, the Digital PCR (dPCR) and Real-time PCR (qPCR) market is segmented into six major regions: North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The Asia Pacific is anticipated to register fastest growth in the Digital PCR (dPCR) and Real-time PCR (qPCR) owing to the increasing incidences of infectious diseases, significant investments by biopharmaceutical companies & CMOs in emerging Asia Pacific countries, and increasing focus on developing advanced healthcare products.
Key players in the Digital PCR (dPCR) and Real-time PCR (qPCR) market include Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Qiagen N.V. (Germany), Abbott Laboratories (US), Biomerieux (France), Becton, Dickinson and Company (US), Agilent Technologies, Inc. (US), Eppendorf AG (Germany), Bio-Rad Laboratories, Inc. (US), Takara Bio Inc. (Japan), Promega Corporation (US), Meridian Bioscience, Inc. (US), ENDRESS+HAUSER (Switzerland), QuidelOrtho Corporation (US), Lepu Medical Technology Beijing Co Ltd. (China), Sysmax Corporation (Japan), and Enzo Biochem, Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Digital PCR (dPCR) and Real-time PCR (qPCR) Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
